Cosmo Technologies Limited

Address: Riverside Two, 43-49 Sir John Rogerson's Quay

Sponsor Overview

assignment

Specializations

bile acid diarrhoea

Research activity in bile acid diarrhoea focuses on treatments aimed at improving stool consistency and controlling symptoms linked to abnormal bile acid handling in the gut. The sponsor’s work in this area is centered on gastrointestinal symptom relief and functional bowel health.

gastrointestinal motility
stool consistency
bile acid malabsorption

The therapeutic interest extends to digestive disorders where restoring bowel function and reducing diarrhoeal burden are key clinical priorities.

ulcerative colitis

Clinical research in ulcerative colitis is directed toward patients with mild to moderate left-sided disease, with attention to achieving clinical remission and reducing inflammatory activity in the colon. This area reflects a focus on bowel inflammation and disease control in inflammatory bowel disease.

colonic inflammation
clinical remission
left-sided colitis

The sponsor’s interest includes local treatment approaches for distal colonic disease and symptom management in gastroenterology.

Trial Name	Country	Status
Efficacy and Safety of Colesevelam Hydrochloride Modified-Release Tablets in Idiopathic Bile Acid Diarrhoea: A Randomized, Double-Blind, Placebo-Controlled Phase II Study	Belgium Denmark Italy Romania Spain	Recruiting
Phase II Randomized, Placebo-Controlled Study of Rifamycin SV Sodium In Situ Gelling Solution for Mild to Moderate Left-Sided Ulcerative Colitis	Bulgaria Estonia Hungary Latvia Lithuania Poland Romania	Not Recruiting